Cancer is the highest single risk factor for thrombosis.

COVID-19 and Thrombosis in Cancer Patients: The Clot Thickens

Prof Alok Khorana looks at hypercoagulability of COVID-19 and strategies and recommendations for anticoagulation.

Read the Article

Thrombosis UK joined with organizations representing patients, nurses and health experts to call on the European Commission to take into account cancer-related complications as it designs its European Beating Cancer Plan.

Patients and experts draw attention to cancer-related conditions.

All Party Parliamentary Group (APG) for Thrombosis March 2020

Report: VTE in Cancer Patients Cancer, Chemotherapy & Clots Survey 2016-1019

Read the Report

Patient Experience of Living With Cancer Associated Thrombosis in France (Le PELICAN)

Isabell Mahe, Jean Chidiac, Mickael Pinson, Parinita Swarnkar, Anne Marie Nelson, Simon Noble - May 2020

Download Report

Warwick Clinical Trials Unit – selected Cancer associated thrombosis – a patient perspective

Cancer-associated thrombosis awareness survey - Results report - October 2018

European Cancer Patient Coalition
With support from LEO Pharma
Carried out by Quality Health Limited

Download Paper

Hospice inpatient deep vein thrombosis detection (HIDDen) in advanced non-malignant diseases’: a longitudinal pilot study - HIDDen Study, 2020

Clare White Simon Noble Flavia Swan Max Watson Victoria Allgar Eoin Napier Annmarie Nelson Miriam J Johnson

View Paper

Setting The scene – the global burden of CAT

Presented by: Lord Kakkar

Clinical decision-making and the role of patient choice

Presented by: Dr Simon Noble

Incidental VTE: Who should we anticoagulate?

Presented by: Dr Anthony Maraveyas


Presented by: Dr Ander Cohen

Anticoagulation for non-valvular AF during chemotherapy

Presented by: Dr Malcolm Walker

Cancer-associated thrombosis: 6 months and beyond

Presented by: Dr Vickie McDonald

Management of CAT - where data is lacking

Presented by: Dr Tim Nokes

IVC filters in CAT management

Presented by: Dr Maeve Crowley